3D screen printing technology enables fabrication of oral dosage forms with freely tailorable drug release profiles – technology and concept well suited for mass production New York, 07/06/2023 / 08:42, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / July 6, 2023 / A study pu.
Laxxon Medical to participate in 2023 BIO International Convention New York, 06/01/2023 / 08:02, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / June 1, 2023 / Laxxon Medical, a pharmatechnology company whose novel platform technology offers unparalleled drug delivery advance.
Laxxon Medical to Participate in 22nd Annual Needham Virtual Healthcare Conference New York, 04/17/2023 / 07:01, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / April 17, 2023 / Laxxon Medical announced today their participation in the 22nd Annual Needham Virtual Healthcare C.
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications New York, 03/27/2023 / 08:00, EST/EDT - EQS Newswire - Laxxon Medical This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture .
Laxxon Medical to Participate in 25th Annual Needham Growth Conference New York, 01/05/2023 / 08:00, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th A.